Lentiviral Vector Applications eBook
Last updated: June 2023
Lentiviral vectors (LVs) are typically derived from HIV and are able to infect both dividing and non-dividing cells, making them useful tools to deliver therapeutic genes to treat genetic disorders or diseases. LVs have been used in numerous cell and gene therapy clinical trials and six therapies based on LVs have been approved by the FDA to date.
Overall, LV production is a complex and challenging process that requires a careful balance between virus yield, purity, and safety. The state of the art continues to evolve, with new technologies and methods being developed to improve the efficiency and safety of LV-based cell and gene therapies.
This eBook features chapters on upstream production, downstream processes, quality control assays and analytics.
Complete the Form to Download the eBook
Applications Supported:
Please select your country so we can show you products that are available for you.
The content of our website is always available in English and partly in other languages. Choose your preferred language and we will show you the content in that language, if available.